KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Working Capital Changes (2016 - 2020)

Thermo Fisher Scientific's Other Working Capital Changes history spans 12 years, with the latest figure at -$410.0 million for Q4 2020.

  • For the quarter ending Q4 2020, Other Working Capital Changes fell 322.83% year-over-year to -$410.0 million, compared with a TTM value of -$1.5 billion through Dec 2020, down 833.33%, and an annual FY2025 reading of $1.3 billion, up 605.38% over the prior year.
  • Other Working Capital Changes for Q4 2020 was -$410.0 million at Thermo Fisher Scientific, up from -$739.0 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $443.0 million in Q1 2020, with the low at -$746.0 million in Q2 2020.
  • Average Other Working Capital Changes over 5 years is -$48.0 million, with a median of $45.4 million recorded in 2016.
  • Year-over-year, Other Working Capital Changes skyrocketed 697.1% in 2017 and then plummeted 985.45% in 2019.
  • Tracing TMO's Other Working Capital Changes over 5 years: stood at $60.7 million in 2016, then tumbled by 231.8% to -$80.0 million in 2017, then crashed by 146.25% to -$197.0 million in 2018, then skyrocketed by 193.4% to $184.0 million in 2019, then crashed by 322.83% to -$410.0 million in 2020.
  • Per Business Quant, the three most recent readings for TMO's Other Working Capital Changes are -$410.0 million (Q4 2020), -$739.0 million (Q3 2020), and -$746.0 million (Q2 2020).